Recombinant Human Tumor Necrosis Factor-α Receptor Ⅱ Fusion Protein in the Treatment of Acute Gout

NCT05925166 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

26

Enrollment

OTHER

Sponsor class

Conditions

Acute Gout

Interventions

DRUG: rhTNFR-Fc
DRUG: methylprednisolone

Sponsor

Lihua Duan